Global Aminocaproic Acid API 麻豆原创 Growth 2025-2031

Publication ID:

LPI08251853

Publication Date:

August 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Manufacturing (Chemicals) [2]

Chemicals [3]

Description:

The global Aminocaproic Acid API market size is predicted to grow from US$ 63.7 million in 2025 to US$ 77.1 million in 2031; it is expected to grow at a CAGR of 3.2% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Aminocaproic acid API is a key intermediate used in the production of antifibrinolytic drug formulations such as injections, oral solutions, and tablets. As an active pharmaceutical ingredient, it works by inhibiting fibrinolysis to achieve hemostatic effects. The API must meet strict pharmacopeial standards, including high purity, controlled impurity levels, moisture content, and low residual metals, to ensure the safety and efficacy of finished products. It is primarily manufactured by GMP-compliant facilities in countries like China and India, and widely exported to global pharmaceutical companies for use in hospital therapies and emergency clinical care.
As a well-established antifibrinolytic active pharmaceutical ingredient, aminocaproic acid API is widely used across the globe. The market is primarily driven by the production of generic formulations, including injections and oral preparations, for controlling bleeding in surgical, hematologic, obstetric, and urologic applications. With a mature synthesis process and stable production costs, countries such as China and India have become leading global suppliers, exporting extensively to regions like North America, Southeast Asia, and the Middle East. In response to tightening global regulations, including drug master file (DMF) registration and generic drug consistency evaluations, buyers are placing increasing emphasis on supplier qualifications, quality systems, and regulatory compliance.The aminocaproic acid API market is expected to exhibit stable and incremental growth in the coming years. Global aging demographics and the rising volume of surgeries will increase clinical demand for antifibrinolytic agents. Meanwhile, Asian manufacturers are poised to further expand their market share, leveraging cost advantages and complete supply chains. A growing number of producers are also shifting towards higher-value segments by developing sterile-grade APIs for injections, pursuing entry into regulated markets such as the U.S., Europe, and Japan, and upgrading production technologies with green chemistry and continuous processing. 麻豆原创 consolidation is likely, with leading GMP-compliant firms that hold DMFs/CEPs and have international audit experience capturing greater market share.The key drivers of this market include stable clinical demand, expanding surgical applications, rising awareness of antifibrinolytic therapy, clearer international regulatory pathways, and increasing global procurement of APIs. Additionally, government policies in several countries encourage the use of generics to reduce healthcare costs, which reinforces demand for cost-effective APIs. However, the sector also faces several constraints: intense price competition, concerns over thrombotic risks leading to usage restrictions in some regions, tightening environmental regulations that raise compliance costs, and the lack of international registration capabilities among small manufacturers. These challenges highlight the need for sustained investment in technology, quality, and regulatory alignment to ensure long-term, sustainable market growth.
The 鈥淎minocaproic Acid API Industry Forecast鈥� looks at past sales and reviews total world Aminocaproic Acid API sales in 2024, providing a comprehensive analysis by region and market sector of projected Aminocaproic Acid API sales for 2025 through 2031. With Aminocaproic Acid API sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Aminocaproic Acid API industry.
This Insight Report provides a comprehensive analysis of the global Aminocaproic Acid API landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Aminocaproic Acid API portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Aminocaproic Acid API market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Aminocaproic Acid API and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Aminocaproic Acid API.
This report presents a comprehensive overview, market shares, and growth opportunities of Aminocaproic Acid API market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Sterile
Non-sterile
Segmentation by Application:
Injection
Tablet
Oral Solutions
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Biophore
Dipharma
Optimus Pharma
MSN Laboratories
Sekisui Medical
Sunny Pharmtech
Hunan Er-Kang Pharmaceutical
Changzhou Lanling Pharmaceutical
Jiangsu Yongan Pharmceutical
Sichuan Renan Pharmaceutical
Key Questions Addressed in this Report
What is the 10-year outlook for the global Aminocaproic Acid API market?
What factors are driving Aminocaproic Acid API market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Aminocaproic Acid API market opportunities vary by end market size?
How does Aminocaproic Acid API break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Aminocaproic Acid API Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Aminocaproic Acid API by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Aminocaproic Acid API by Country/Region, 2020, 2024 & 2031
2.2 Aminocaproic Acid API Segment by Type
2.2.1 Sterile
2.2.2 Non-sterile
2.3 Aminocaproic Acid API Sales by Type
2.3.1 Global Aminocaproic Acid API Sales 麻豆原创 Share by Type (2020-2025)
2.3.2 Global Aminocaproic Acid API Revenue and 麻豆原创 Share by Type (2020-2025)
2.3.3 Global Aminocaproic Acid API Sale Price by Type (2020-2025)
2.4 Aminocaproic Acid API Segment by Application
2.4.1 Injection
2.4.2 Tablet
2.4.3 Oral Solutions
2.4.4 Other
2.5 Aminocaproic Acid API Sales by Application
2.5.1 Global Aminocaproic Acid API Sale 麻豆原创 Share by Application (2020-2025)
2.5.2 Global Aminocaproic Acid API Revenue and 麻豆原创 Share by Application (2020-2025)
2.5.3 Global Aminocaproic Acid API Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Aminocaproic Acid API Breakdown Data by Company
3.1.1 Global Aminocaproic Acid API Annual Sales by Company (2020-2025)
3.1.2 Global Aminocaproic Acid API Sales 麻豆原创 Share by Company (2020-2025)
3.2 Global Aminocaproic Acid API Annual Revenue by Company (2020-2025)
3.2.1 Global Aminocaproic Acid API Revenue by Company (2020-2025)
3.2.2 Global Aminocaproic Acid API Revenue 麻豆原创 Share by Company (2020-2025)
3.3 Global Aminocaproic Acid API Sale Price by Company
3.4 Key Manufacturers Aminocaproic Acid API Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Aminocaproic Acid API Product Location Distribution
3.4.2 Players Aminocaproic Acid API Products Offered
3.5 麻豆原创 Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 麻豆原创 M&A Activity & Strategy
4 World Historic Review for Aminocaproic Acid API by Geographic Region
4.1 World Historic Aminocaproic Acid API 麻豆原创 Size by Geographic Region (2020-2025)
4.1.1 Global Aminocaproic Acid API Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Aminocaproic Acid API Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Aminocaproic Acid API 麻豆原创 Size by Country/Region (2020-2025)
4.2.1 Global Aminocaproic Acid API Annual Sales by Country/Region (2020-2025)
4.2.2 Global Aminocaproic Acid API Annual Revenue by Country/Region (2020-2025)
4.3 Americas Aminocaproic Acid API Sales Growth
4.4 APAC Aminocaproic Acid API Sales Growth
4.5 Europe Aminocaproic Acid API Sales Growth
4.6 Middle East & Africa Aminocaproic Acid API Sales Growth
5 Americas
5.1 Americas Aminocaproic Acid API Sales by Country
5.1.1 Americas Aminocaproic Acid API Sales by Country (2020-2025)
5.1.2 Americas Aminocaproic Acid API Revenue by Country (2020-2025)
5.2 Americas Aminocaproic Acid API Sales by Type (2020-2025)
5.3 Americas Aminocaproic Acid API Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Aminocaproic Acid API Sales by Region
6.1.1 APAC Aminocaproic Acid API Sales by Region (2020-2025)
6.1.2 APAC Aminocaproic Acid API Revenue by Region (2020-2025)
6.2 APAC Aminocaproic Acid API Sales by Type (2020-2025)
6.3 APAC Aminocaproic Acid API Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Aminocaproic Acid API by Country
7.1.1 Europe Aminocaproic Acid API Sales by Country (2020-2025)
7.1.2 Europe Aminocaproic Acid API Revenue by Country (2020-2025)
7.2 Europe Aminocaproic Acid API Sales by Type (2020-2025)
7.3 Europe Aminocaproic Acid API Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Aminocaproic Acid API by Country
8.1.1 Middle East & Africa Aminocaproic Acid API Sales by Country (2020-2025)
8.1.2 Middle East & Africa Aminocaproic Acid API Revenue by Country (2020-2025)
8.2 Middle East & Africa Aminocaproic Acid API Sales by Type (2020-2025)
8.3 Middle East & Africa Aminocaproic Acid API Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Aminocaproic Acid API
10.3 Manufacturing Process Analysis of Aminocaproic Acid API
10.4 Industry Chain Structure of Aminocaproic Acid API
11 麻豆原创ing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Aminocaproic Acid API Distributors
11.3 Aminocaproic Acid API Customer
12 World Forecast Review for Aminocaproic Acid API by Geographic Region
12.1 Global Aminocaproic Acid API 麻豆原创 Size Forecast by Region
12.1.1 Global Aminocaproic Acid API Forecast by Region (2026-2031)
12.1.2 Global Aminocaproic Acid API Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Aminocaproic Acid API Forecast by Type (2026-2031)
12.7 Global Aminocaproic Acid API Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Biophore
13.1.1 Biophore Company Information
13.1.2 Biophore Aminocaproic Acid API Product Portfolios and Specifications
13.1.3 Biophore Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Biophore Main Business Overview
13.1.5 Biophore Latest Developments
13.2 Dipharma
13.2.1 Dipharma Company Information
13.2.2 Dipharma Aminocaproic Acid API Product Portfolios and Specifications
13.2.3 Dipharma Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Dipharma Main Business Overview
13.2.5 Dipharma Latest Developments
13.3 Optimus Pharma
13.3.1 Optimus Pharma Company Information
13.3.2 Optimus Pharma Aminocaproic Acid API Product Portfolios and Specifications
13.3.3 Optimus Pharma Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Optimus Pharma Main Business Overview
13.3.5 Optimus Pharma Latest Developments
13.4 MSN Laboratories
13.4.1 MSN Laboratories Company Information
13.4.2 MSN Laboratories Aminocaproic Acid API Product Portfolios and Specifications
13.4.3 MSN Laboratories Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 MSN Laboratories Main Business Overview
13.4.5 MSN Laboratories Latest Developments
13.5 Sekisui Medical
13.5.1 Sekisui Medical Company Information
13.5.2 Sekisui Medical Aminocaproic Acid API Product Portfolios and Specifications
13.5.3 Sekisui Medical Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Sekisui Medical Main Business Overview
13.5.5 Sekisui Medical Latest Developments
13.6 Sunny Pharmtech
13.6.1 Sunny Pharmtech Company Information
13.6.2 Sunny Pharmtech Aminocaproic Acid API Product Portfolios and Specifications
13.6.3 Sunny Pharmtech Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Sunny Pharmtech Main Business Overview
13.6.5 Sunny Pharmtech Latest Developments
13.7 Hunan Er-Kang Pharmaceutical
13.7.1 Hunan Er-Kang Pharmaceutical Company Information
13.7.2 Hunan Er-Kang Pharmaceutical Aminocaproic Acid API Product Portfolios and Specifications
13.7.3 Hunan Er-Kang Pharmaceutical Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Hunan Er-Kang Pharmaceutical Main Business Overview
13.7.5 Hunan Er-Kang Pharmaceutical Latest Developments
13.8 Changzhou Lanling Pharmaceutical
13.8.1 Changzhou Lanling Pharmaceutical Company Information
13.8.2 Changzhou Lanling Pharmaceutical Aminocaproic Acid API Product Portfolios and Specifications
13.8.3 Changzhou Lanling Pharmaceutical Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Changzhou Lanling Pharmaceutical Main Business Overview
13.8.5 Changzhou Lanling Pharmaceutical Latest Developments
13.9 Jiangsu Yongan Pharmceutical
13.9.1 Jiangsu Yongan Pharmceutical Company Information
13.9.2 Jiangsu Yongan Pharmceutical Aminocaproic Acid API Product Portfolios and Specifications
13.9.3 Jiangsu Yongan Pharmceutical Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Jiangsu Yongan Pharmceutical Main Business Overview
13.9.5 Jiangsu Yongan Pharmceutical Latest Developments
13.10 Sichuan Renan Pharmaceutical
13.10.1 Sichuan Renan Pharmaceutical Company Information
13.10.2 Sichuan Renan Pharmaceutical Aminocaproic Acid API Product Portfolios and Specifications
13.10.3 Sichuan Renan Pharmaceutical Aminocaproic Acid API Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Sichuan Renan Pharmaceutical Main Business Overview
13.10.5 Sichuan Renan Pharmaceutical Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.